Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PPIs for Postoperative Outcomes After Pancreaticoduodenectomy
NCT05251233Phase 2Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Apr 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroparesis and Marginal ulcer comparing Placebo Arm with Pantoprazole Arm (2 arms). Primary endpoints: Delayed Gastric Emptying by ISGPS Criteria at 90 days and Delayed Gastric Emptying by Modified Accordion Grading System at 90 days. Started Apr 2022; status: terminated.
02
Drugs
pantoprazole
03
Conditions
gastroparesisMarginal ulcer
Beyond the preview
Go deeper on NCT05251233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05251233.